Here is the latest shareholding Pattern of BRAWN BIOTECH. For more details, see the BRAWN BIOTECH financial fact sheet and BRAWN BIOTECH share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 53.73 | 53.73 | 53.72 | 53.72 | 53.72 | 53.72 | 53.72 | 53.64 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 53.73 | 53.73 | 53.72 | 53.72 | 53.72 | 53.72 | 53.72 | 53.64 | |
Mutual Funds | % | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.35 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.35 | |
Bodies Corporate | % | 0.58 | 0.58 | 0.58 | 0.57 | 0.57 | 0.57 | 0.57 | 0.42 | |
Individuals | % | 42.37 | 42.52 | 42.44 | 42.70 | 42.87 | 42.89 | 42.90 | 33.91 | |
NRIs/OCBs | % | 2.57 | 2.58 | 2.50 | 2.23 | 2.25 | 2.23 | 2.22 | 1.20 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 0.16 | -0.00 | 0.17 | 0.19 | -0.00 | -0.00 | -0.00 | 10.48 | |
Total Non-Institution | % | 45.68 | 45.68 | 45.69 | 45.69 | 45.69 | 45.69 | 45.69 | 46.01 | |
Total Public | % | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Trading Company Shareholding Pattern: CIPLA ZYDUS LIFESCIENCES DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.